SEC Form 4 · accession 0001177648-18-000001
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathaniel S. Gardiner
Officer — Sr. VP & General Counsel
Period of report
Feb 8, 2018
Accepted (ET)
Feb 12, 2018 · 5:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 8, 2018 | M | 4,300 | $34.70 | A | 7,570 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $34.70 | Feb 8, 2018 | M | 4,300 | D | — | May 9, 2024 | Common Stock | 4,300 | 78,200 | D |
Explanation of responses
- F1This option to purchase a total of 82,500 shares of common stock became exercisable with respect to twenty-five percent (25%) of the shares on May 9, 2015 (the "Anniversary Date"), with the remainder becoming exercisable quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over three years from the Anniversary Date.